Peritoneal Carcinomatosis — Trials

Peritoneal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 42
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: University of California, Irvine
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07487168	Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors	recruiting	Phase 1	24	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 16, 2026	clinicaltrials
NCT04329494	PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer	recruiting	Phase 1	49	City of Hope Medical CenterOTHER	1	Aug 26, 2026	clinicaltrials